Cytotoxic and HLE-inhibitory tetramic acid derivatives from marine-derived fungi

Natural Product Communications

Volumn 4, Issue 3, 2009, Pages 347-354

  Neumann, Kerstin ^a   Kehraus, Stefan ^a   Gütschow, Michael ^a   König, Gabriele M ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Marine fungi; Natural products; Tetramic acid

Indexed keywords

2 FUROIC ACID; 5 HYDROXYMETHYL FURAN 2 CARBOXYLIC ACID; ACETYLCHOLINESTERASE; BEAUVERICIN; BEAUVERSETIN; FURAN DERIVATIVE; LEUKOCYTE ELASTASE; PROPIDIUM IODIDE; SCH210972; TETRAMIC ACID DERIVATIVE; UNCLASSIFIED DRUG; 2 PYRROLIDONE DERIVATIVE; AMINE OXIDE; TETRAMIC ACID;

AGAR DIFFUSION; ANTINEOPLASTIC ACTIVITY; ARTICLE; BACILLUS MEGATERIUM; BEAUVERIA BASSIANA; CARBON NUCLEAR MAGNETIC RESONANCE; CHLORELLA; CHROMOBACTERIUM VIOLACEUM; DRUG CYTOTOXICITY; DRUG ISOLATION; ENZYME INHIBITION; ESCHERICHIA COLI; EUROTIUM; FUNGUS; FUNGUS ISOLATION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IC 50; MARINE SPECIES; MASS SPECTROMETRY; MICRODIPLODIA; MICROSPORIDIA; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROTON NUCLEAR MAGNETIC RESONANCE; TUMOR CELL LINE; ANIMAL; ASCOMYCETES; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECT; ISOLATION AND PURIFICATION; MICROBIOLOGY; SPONGE (PORIFERA);

CORDYCEPS BASSIANA; FUNGI;

ANIMALS; CYCLIC N-OXIDES; HYPOCREALES; LEUKOCYTE ELASTASE; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR STRUCTURE; PORIFERA; PYRROLIDINONES;

EID: 66149099221     PISSN: 1934578X     EISSN: 15559475     Source Type: Journal    
DOI: 10.1177/1934578x0900400308     Document Type: Article

References (38)

1. Royles BJL. (1995) Naturally occurring tetramic acids: structure, isolation, and synthesis. Chemical Reviews, 95, 1981-2001.
2. Hopmann C, Kurz M, Brönstrup M, Wink J, LeBeller D. (2002) Isolation and structure elucidation of vancoresmycin - a new antibiotic from Amycolatopsis sp ST 101170. Tetrahedron Letters, 43, 435-438. (Pubitemid 34037919)
3. Karwowski JP, Jackson M, Theriault RJ, Barlow GJ, Coen L, Hensey DM, Humphrey PE. (1992) Tirandalydigin, a novel tetramic acid of the tirandamycin-streptolydigin type. Journal of Antibiotics, 45, 1125-1132.
4. Wolf D, Schmitz FJ, Qiu, F, Kelly-Borges M. (1999) Aurantoside C, a new tetramic acid glycoside from the sponge Homophymia conferta. Journal of Natural Products, 62, 170-172. (Pubitemid 29071406)
5. Lang G, Cole ALJ, Blunt JW, Munro MHG. (2006) An unusual oxalylated tetramic acid from the New Zealand basidiomycete Chamonixia pachydermis. Journal of Natural Products, 69, 151-153. (Pubitemid 43241776)
6. Reusser F. (1976) Tirandamycin, an inhibitor of bacterial ribonucleic acid polymerase. Antimicrobial Agents and Chemotherapy, 10, 618-622.
7. Larbig G, Schmidt B. (2006) Synthesis of tetramic and tetronic acids as beta-secretase inhibitors. Journal of Combinatorial Chemistry, 8, 480-490. (Pubitemid 44116110)
8. Schobert R, Schlenk A. (2008) Tetramic and tetronic acids: An update on new derivatives and biological aspects. Bioorganic and Medicinal Chemistry, 16, 4203-4221. (Pubitemid 351539040)
9. Vesonder RF, Tjarks LW, Rohwedder WK, Burmeister HR, Laugal JA. (1979) Equisetin, an antibiotic from Fusarium-equiseti NRRL-5537, identified as a derivative of N-methyl-2,4-pyrrolidinone. Journal of Antibiotics, 32, 759-761.
10. Marfori EC, Kajiyama S, Fukusaki E, Kobayashi A. (2002) Trichosetin, a novel tetramic acid antibiotic produced in dual culture of Trichoderma harzianum and Catharanthus roseus callus. Zeitschrift für Naturforschung, 57c, 465-470.
11. Lang G, Blunt JW, Cummings NJ, Cole ALJ, Munro MHG. (2005) Paecilosetin, a new bioactive fungal metabolite from a New Zealand isolate of Paecilomyces farinosus. Journal of Natural Products, 68, 810-811.
12. Segeth MP, Bonnefoi A, Brönstrup M, Knauf M, Schummer D, Toti L, Vértesy L, Wetzel-Raynal MC, Wink J, Seibert G.(2003) Coniosetin, a novel tetramic acid antibiotic from Coniochaeta ellipsoidea DSM 13856. Journal of Antibiotics, 56, 114-122. (Pubitemid 36372793)
13. Koyama N, Nagahiro T, Yamaguchi Y, Ohshiro T, Masuma R, Tomoda H, Ōmura S. (2005) Spylidone, a novel inhibitor of lipid droplet accumulation in mouse macrophages produced by Phoma sp. FKI-1840. Journal of Antibiotics, 58, 338-345. (Pubitemid 40874452)
14. Hellwig V, Grothe T, Mayer-Bartschmid A, Endermann R, Geschke F-U, Henkel T, Stadler M. (2002) Altersetin, a new antibiotic from cultures of endophytic Alternaria spp. Taxonomy, fermentation, isolation, structure elucidation and biological activities. Journal of Antibiotics, 55, 881-892. (Pubitemid 35315003)
15. Devi KU, Reineke A, Reddy NNR, Rao CUM, Padmavathi J. (2006) Genetic diversity, reproductive biology, and speciation in the entomopathogenic fungus Beauveria bassiana (Balsamo) Vuillemin. Genome, 49, 495-504.
16. Hamill RL, Higgens CE, Boaz HE, Gorman M. (1969) Structure of beauvericin, a new depsipeptide antibiotic toxic to Artemia salina. Tetrahedron Letters, 10, 4255-4258.
17. Nakajyo S, Shimizu K, Kometani A, Kato K, Kamizaki J, Isogai A, Urakawa N. (1982) Inhibitory effect of bassianolide, a cyclodepsipeptide, on drug-induced constractions of isolated smooth-muscle preparations. The Japanese Journal of Pharmacology, 32, 55-64. (Pubitemid 12187932)
18. Namatame I, Tomoda H, Si S, Yamaguchi Y, Masuma R, Ōmura S. (1999) Beauveriolides, specific inhibitors of lipid droplet formation in mouse macrophages, produced by Beauveria sp. FO-6979. Journal of Antibiotics, 52, 1-6. (Pubitemid 29070581)
19. Wat CK, McInnes AG, Smith DG, Wright JC, Vining LC. (1977) Yellow pigments of Beauveria species - structures of tenellin and bassianin. Canadian Journal of Chemistry, 55, 4090-4098.
20. Wainwright M, Betts RP. (1986) Antibiotic-activity of oosporein from Verticillum psalliotae. Transactions of the British Mycological Society, 86, 168-170.
21. Humphreys-Jones DR. (1981) Stem rot (Microdiplodia ceanothi) of Ceanothus dentatus. Plant Pathology, 30, 62-63.
22. Hussain H, Krohn K, Floerke U, Schulz B, Draeger S, Pescitelli G, Antus S, Kurtán T. (2007) Absolute configurations of globosuxanthone A and secondary metabolites from Microdiplodia sp. - A novel solid-state CD/TDDFT approach. European Journal of Organic Chemistry, 292-295.
23. Gunasekera SP, Gunasekera M, McCarthy P. (1991) Discodermide: a new bioactive macrocyclic lactam from the marine sponge Discodermia dissolute. Journal of Organic Chemistry, 56, 4830-4833.
24. Klemke C. (2004) Isolation, cultivation and biological screening of marine endophytic fungi and structure elucidation of new fungal secondary metabolites. Dissertation, University of Bonn.
25. Yang SW, Mierzwa R, Terraciano J, Patel M, Gullo V, Wagner N, Baroudy B, Puar M, Chan TM, McPhail AT, Chu M. (2006) Chemokine receptor CCR-5 inhibitors produced by Chaetomium globosum. Journal of Natural Products, 69, 1025-1028.
26. Young RE, Thompson RD, Larbi KY, La M, Roberts CE, Shapiro SD, Perretti M, Nourshargh S. (2004) Neutrophil elastase (NE)- deficient mice demonstrate a nonredundant role for NE in neutrophil migration, generation of proinflammatory mediators, and phagocytosis in response to zymosan particles in vivo. Journal of Immunology, 172, 4493-4502.
27. Janoff A. (1985) Elastase and emphysema - current assessment of the protease-antiprotease hypothesis. American Review of Respiratory Disease, 132, 417-433.
28. Llewellyn-Jones CG, Harris TAJ, Stockley RA. (1996) Effect of fluticasone propionate on sputum of patients with chronic bronchitis and emphysema. American Journal of Respiratory and Critical Care Medicine, 153, 616-621.
29. Lee CT, Fein AM, Lippmann M, Holtzmann H, Kimbel P, Weinbaum, G. (1981) Elastolytic activity in pulmonary lavage fluid from patients with adult respiratory-distress syndrome. New England Journal of Medicine, 304, 192-196.
30. Varga M, Kapui Z, Bátori S, Nagy LT, Vasvári-Debreczy L, Mikus E, Urbán-Szabó K, Arányi P. (2003) A novel orally active inhibitor of HLE. European Journal of Medicinal Chemistry, 38, 421-425.
31. Adeyemi EO, Neumann S, Chadwick VS, Hodgson HJF, Pepys MB. (1985) Circulatin human-leukocyte elastase in patients with inflammatory bowel-disease. Gut, 26, 1306-1311.
32. Pham CTN. (2006) Neutrophil serine proteases: specific regulators of inflammation. Nature Reviews Immunology, 6, 541-550.
33. Singh SB, Zink DL, Goetz MA, Dombrowski AW, Polishook JD, Hazuda DJ. (1998) Equisetin and a novel opposite stereochemical homolog phomasetin, two fungal metabolites as inhibitors of HIV-1 integrase. Tetrahedron Letters, 39, 2243-2246.
34. Phillips NJ, Goodwin JT, Fraiman A, Cole RJ, Lynn DG. (1989) Characterization of the fusarium toxin equisetin - the use of phenylboronates in structure assignment. Journal of the American Chemical Society, 111, 8223-8231.
35. Schulz B, Sucker J, Aust HJ, Krohn K, Ludewig K, Jones PG, Döring D. (1995) Biologically-active secondary metabolites of endophytic Pezicula species. Mycological Research, 99, 1007-1015.
36. Dengler WA, Schulte J, Berger DP, Mertelsmann R, Fiebig HH. (1995) Development of a propidium iodide fluorescence assay for proliferation and cytotoxicity assays. Anticancer Drugs, 6, 522-532.
37. Eifeld A, González Tanarro CM, Frizler M, Sieler J, Schulze B, Gütschow M. (2008) Synthesis and elastase-inhibiting activity of 2-pyridinyl-isothiazol-3(2H)-one 1,1-dioxides. Bioorganic and Medicinal Chemistry, 16, 8127-8135.
38. Gütschow M, Pietsch M, Themann A, Fahrig J, Schulze B. (2005) 2,4,5-triphenylisothiazol-3(2H)-one 1,1-dioxides as inhibitors of human leukocyte elastase. Journal of Enzyme Inhibition and Medicinal Chemistry, 20, 341-347.